Advanced Enzyme Technologies Approves Equity Share Buyback

Advanced Enzyme Technologies Ltd. announced its Board of Directors has approved a buyback of equity shares. The buyback will be conducted through the open market route on the stock exchanges, up to 10% of the company's paid-up capital and free reserves. The maximum buyback price is set at ₹500 per share, with an aggregate amount not exceeding ₹697,000,000. This represents approximately 9.99% of the company's paid-up capital and free reserves based on its last audited standalone financial statements as of March 31, 2026. The buyback excludes shares held by promoters and promoter group members. The company will utilize its securities premium account, free reserves, or other permitted sources, and will not use borrowed funds. The buyback is subject to regulatory approvals and compliance with minimum public shareholding requirements.